Latest:
Dr. Osipov on the Role of Combination Immunotherapy Across Multiple Tumor Types
Arsen Osipov, MD, discusses the role of combination immunotherapy across multiple tumor types.
- Advertise
- About OncLive
- Editorial Board
- MJH Life Sciences brands
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2025 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Authors
Mark H. Bilsky, MD
Latest:
Overall Survival After Surgery for Spinal Metastases Has Improved Over the Past Two Decades
Postoperative survival after surgery for spinal metastases has improved over the past 20 years, particularly in patients with kidney, breast, lung, and colon tumors metastatic to the spine.
Peter J. DeMaria, MD, and Jennifer J. Gao, MD
Latest:
Career Options for Graduating Oncology Fellows at the NIH and FDA
Peter J. DeMaria, MD and Jennifer J. Gao, MD shed light on how graduating fellows seeking a rewarding and intellectually challenging career on the frontier of cancer drug development could be well served to consider a position of federal service at the NIH or FDA.
Foluso Bisi Ademuyiwa, MD, MPH, MSCI
Latest:
Dr Ademuyiwa on the Sequencing of First-line CDK4/6 Inhibitors in HR+/HER2– Breast Cancer
Foluso Bisi Ademuyiwa, MD, MPH, MSCI, discusses the optimal sequencing of current CDK4/6 inhibitors in the first-line setting for hormone receptor (HR)–positive, HER2-negative breast cancer based on updated efficacy and safety data.
Kim N. Chi, MD, BC Cancer
Latest:
Rapid Readouts: Final Analysis Results From the Phase 3 TITAN Study
Kim N. Chi, MD, presents slides from the 2021 ASCO Genitourinary Cancers Symposium for the final results from the phase 3 TITAN study of apalutamide versus placebo in patients with metastatic castration-sensitive prostate cancer receiving androgen deprivation therapy.